#1 Clinical Trials Search in Europe

Oxybuprocaine

Oxybuprocaine, also known as benoxinate, is a local anesthetic commonly used in ophthalmic procedures. This article explores various clinical trials investigating the efficacy and safety of oxybuprocaine in different eye-related medical applications. From pain management in premature infants to anesthesia for cataract surgery, these studies provide valuable insights into the drug’s potential benefits and considerations.

Table of Contents

What is Oxybuprocaine?

Oxybuprocaine, also known as Benoxinate, is a type of medication used as a topical anesthetic for the eye[1]. It belongs to a class of drugs called local anesthetics, which work by temporarily numbing a specific area of the body. In the case of Oxybuprocaine, it’s specifically designed for use on the surface of the eye[2].

Uses of Oxybuprocaine

Oxybuprocaine is primarily used in various eye procedures and examinations. Some of its common uses include:

  • Retinopathy of Prematurity (ROP) Screening: It’s used to reduce pain during eye examinations in premature infants[3].
  • Cataract Surgery: It provides topical anesthesia for the eye during cataract removal procedures[4].
  • Laser Eye Surgery: It’s used as an anesthetic during procedures like SMILE (Small Incision Lenticule Extraction) for correcting myopia (short-sightedness)[5].
  • General Eye Examinations: It can be used to numb the eye surface for various diagnostic procedures[2].

How Oxybuprocaine is Administered

Oxybuprocaine is typically administered as eye drops. The concentration commonly used is 0.4%. Here’s how it’s usually given:

  • The drops are instilled directly onto the surface of the eye.
  • Depending on the procedure, one or two drops may be given.
  • In some cases, the drops might be given a few minutes apart to ensure proper numbing[6].

It’s important to note that Oxybuprocaine should only be administered by healthcare professionals or under their direct supervision.

Effectiveness and Safety

Several studies have investigated the effectiveness and safety of Oxybuprocaine:

  • In premature infants undergoing ROP screening, Oxybuprocaine has shown potential in reducing pain scores[3].
  • For cataract surgeries, it provides effective topical anesthesia when combined with conscious sedation[4].
  • In laser eye surgeries like SMILE, it’s used successfully as part of the anesthetic regimen[5].

While generally considered safe when used as directed, ongoing research continues to evaluate its long-term effects and optimal usage protocols.

Comparison with Other Anesthetics

Oxybuprocaine is often compared to or used in combination with other topical anesthetics:

  • Chloroprocaine: A study is comparing the efficacy of Chloroprocaine gel to Oxybuprocaine drops for pediatric eye examinations[1].
  • Proxymetacaine: Sometimes used in combination with Oxybuprocaine for procedures like SMILE[5].
  • Preservative-free formulations: Some studies are exploring the use of preservative-free Oxybuprocaine for better tolerability[6].

Potential Side Effects

While Oxybuprocaine is generally safe when used as directed, it can have some side effects. These may include:

  • Temporary stinging or burning sensation when applied
  • Blurred vision for a short time after application
  • In rare cases, allergic reactions

It’s important to note that prolonged or frequent use of topical anesthetics like Oxybuprocaine can potentially damage the cornea (the clear front part of the eye). Therefore, these medications should only be used under the supervision of an eye care professional[6].

Aspect Details
Primary Uses Topical anesthesia for ophthalmic procedures (ROP screening, cataract surgery, PRK)
Concentration Typically 0.4% in eye drop form
Efficacy Shown to reduce pain scores in various procedures
Safety Considerations Potential effects on corneal healing, endothelial cell density, and ocular microbiome under investigation
Comparative Studies Being compared to other anesthetics like chloroprocaine for efficacy and safety
Patient Populations Used in premature infants, pediatric patients, and adults
Administration Multiple drops before procedures or at specific intervals during/after procedures

FAQ

  • What is oxybuprocaine used for in clinical trials? Oxybuprocaine is primarily used as a topical anesthetic in various ophthalmic procedures, including retinopathy of prematurity screening, cataract surgery, and photorefractive keratectomy (PRK). It helps reduce pain and discomfort during eye examinations and surgeries.
  • How effective is oxybuprocaine in reducing pain during eye procedures? Several studies have shown that oxybuprocaine is effective in reducing pain during eye procedures. For example, in retinopathy of prematurity screening, it has been found to lower pain scores in premature infants. In cataract surgeries, it provides adequate topical anesthesia when combined with conscious sedation.
  • Are there any side effects associated with oxybuprocaine use? While oxybuprocaine is generally considered safe, some studies are investigating potential side effects. These may include temporary changes in corneal epithelial healing, endothelial cell density, and ocular surface microbiome. However, more research is needed to fully understand these effects.
  • How is oxybuprocaine administered in clinical trials? Oxybuprocaine is typically administered as eye drops. The concentration used in most trials is 0.4%. In some studies, it is given as multiple drops before a procedure, while in others, it may be administered at specific intervals during and after the procedure.
  • How does oxybuprocaine compare to other topical anesthetics? Some trials are comparing oxybuprocaine to other topical anesthetics like chloroprocaine. For instance, one study is investigating the efficacy and safety of chloroprocaine 3% gel compared to oxybuprocaine 0.4% eye drops in pediatric patients. These comparisons help determine the most effective and safe options for different procedures and patient populations.

Ongoing Clinical Trials on Oxybuprocaine

  • Study on the Effectiveness of Chloroprocaine Gel and Oxybuprocaine Drops for Eye Anesthesia in Children Needing Eye Exams

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Italy

Glossary

  • Oxybuprocaine: A local anesthetic drug used in eye drops for numbing the surface of the eye during examinations or minor surgical procedures.
  • Retinopathy of Prematurity (ROP): An eye disorder that primarily affects premature infants, potentially leading to vision problems or blindness if left untreated.
  • Premature Infant Pain Profile (PIPP): A scoring system used to assess pain in premature infants, considering factors like heart rate, oxygen saturation, and facial expressions.
  • Topical Anesthesia: The application of anesthetic drugs to a specific area of the body's surface, such as the eye, to numb sensation in that area.
  • Photorefractive Keratectomy (PRK): A type of laser eye surgery used to correct nearsightedness, farsightedness, and astigmatism by reshaping the cornea.
  • Corneal Epithelium: The outermost layer of the cornea, which plays a crucial role in maintaining eye health and clear vision.
  • Endothelial Cell Density (ECD): A measure of the number of endothelial cells in the cornea, which is important for maintaining corneal clarity and function.
  • Ocular Surface Microbiome: The community of microorganisms that naturally inhabit the surface of the eye and surrounding tissues.
  • Conscious Sedation: A combination of medicines to help you relax and block pain during a medical procedure while you stay awake.
  • Visual Analogue Scale (VAS): A measurement instrument used to assess subjective characteristics or attitudes that cannot be directly measured, often used for pain assessment.

References

  1. https://clinicaltrials.gov/study/NCT05926258
  2. https://clinicaltrials.gov/study/NCT04193774
  3. https://clinicaltrials.gov/study/NCT06461975
  4. https://clinicaltrials.gov/study/NCT03933280
  5. https://clinicaltrials.gov/study/NCT02528123
  6. https://clinicaltrials.gov/study/NCT05733741